Cargando…

Pharmacologic Management for Ventricular Arrhythmias: Overview of Anti-Arrhythmic Drugs

Ventricular arrhythmias (Vas) are a life-threatening condition and preventable cause of sudden cardiac death (SCD). With the increased utilization of implantable cardiac defibrillators (ICD), the focus of VA management has shifted toward reduction of morbidity from VAs and ICD therapies. Anti-arrhyt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Larson, John, Rich, Lucas, Deshmukh, Amrish, Judge, Erin C., Liang, Jackson J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181251/ https://www.ncbi.nlm.nih.gov/pubmed/35683620 http://dx.doi.org/10.3390/jcm11113233

Ejemplares similares

Mitochondrial Dysfunction Increases Arrhythmic Triggers and Substrates; Potential Anti-arrhythmic Pharmacological Targets
por: Saadeh, Khalil, et al.
Publicado: (2021)

Cardiac Involvement and Arrhythmias Associated with Myotonic Dystrophy
por: McBride, Daniel, et al.
Publicado: (2022)

Atrial Arrhythmias and Electroanatomical Remodeling in Patients With Left Ventricular Assist Devices
por: Deshmukh, Amrish, et al.
Publicado: (2017)

Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy
por: Passini, Elisa, et al.
Publicado: (2016)

Ventricular arrhythmias in nonischemic cardiomyopathy: Overview
por: Kusano, Kengo
Publicado: (2018)

Is CRT pro-arrhythmic? A comparative analysis of the occurrence of ventricular arrhythmias between patients implanted with CRTs and ICDs
por: Gopalamurugan, A. B., et al.
Publicado: (2014)

Ventricular arrhythmias in arrhythmic mitral valve syndrome—a prospective continuous long-term cardiac monitoring study
por: Aabel, Eivind W, et al.
Publicado: (2022)

Interactions of Rosiglitazone and Anti-Arrhythmic Drugs in Animal Model
por: Mohammed, YM, et al.
Publicado: (2012)

Clock-Modulating Activities of the Anti-Arrhythmic Drug Moricizine
por: Han, Chorong, et al.
Publicado: (2021)

Cardiac arrhythmias in COVID-19 patients: A combination of viral comorbidities and pro-arrhythmic drug interactions
por: Ehrlich, Haley, et al.
Publicado: (2021)

Propofol in ICU Settings: Understanding and Managing Anti-Arrhythmic, Pro-Arrhythmic Effects, and Propofol Infusion Syndrome
por: Paramsothy, Jananthan, et al.
Publicado: (2023)

Omega-3 Fatty Acids: Anti-Arrhythmic, Pro-Arrhythmic, or Both?
por: von Schacky, C.
Publicado: (2012)

Ventricular anti-arrhythmic effects of heptanol in hypokalaemic, Langendorff-perfused mouse hearts
por: TSE, GARY, et al.
Publicado: (2016)

Clinical Impact of Circulating Galectin-3 on Ventricular Arrhythmias and Heart Failure Hospitalization Independent of Prior Ventricular Arrhythmic Events in Patients with Implantable Cardioverter-defibrillators
por: Makimoto, Hisaki, et al.
Publicado: (2022)

Ventricular fibrillation ablation in cardiomyopathies and arrhythmic storm
por: Pappone, Carlo, et al.
Publicado: (2021)

Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: Anti-arrhythmic Drug for Arrhythmogenic Right Ventricular Cardiomyopathy
por: Tu, Bin, et al.
Publicado: (2021)

Hydrogen Sulfide—a potent multichannel anti-arrhythmic drug
por: Zhong, Guang-Zhen
Publicado: (2010)

New Progress in Understanding the Cellular Mechanisms of Anti-arrhythmic Drugs
por: An, Zhe, et al.
Publicado: (2018)

Anti-arrhythmic drugs in atrial fibrillation: tailor-made treatments
por: Capucci, Alessandro, et al.
Publicado: (2023)

New drug discovery of cardiac anti-arrhythmic drugs: insights in animal models
por: Sharma, Ashish Kumar, et al.
Publicado: (2023)

COVID-19 treatments, QT interval, and arrhythmic risk: The need for an international registry on arrhythmias
por: Crotti, Lia, et al.
Publicado: (2020)

Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy
por: Gasperetti, Alessio, et al.
Publicado: (2023)

Fetal Arrhythmia Diagnosis and Pharmacologic Management
por: Strasburger, Janette F., et al.
Publicado: (2022)

Contemporary Management of Complex Ventricular Arrhythmias
por: Wiles, Benedict M, et al.
Publicado: (2022)

The Modern Treatment of Ventricular Arrhythmias: Drugs or Defibrillators
por: Gill, J S
Publicado: (1999)

COVID-19 and arrhythmia: An overview
por: Varney, Joseph A, et al.
Publicado: (2022)

Network Pharmacology-Based Systematic Analysis of Molecular Mechanisms of Dingji Fumai Decoction for Ventricular Arrhythmia
por: Liang, Yi, et al.
Publicado: (2021)

Arrhythmic syncope: From diagnosis to management
por: Francisco Pascual, Jaume, et al.
Publicado: (2023)

Management of the arrhythmic manifestations of cardiac sarcoidosis
por: Cherrett, Callum, et al.
Publicado: (2023)

Anti-arrhythmic properties of non-antiarrhythmic medications
por: Williams, Emmanuel Ato, et al.
Publicado: (2020)

Ventricular Conduction Stability Noninvasively Identifies an Arrhythmic Substrate in Survivors of Idiopathic Ventricular Fibrillation
por: Chow, Ji‐Jian, et al.
Publicado: (2023)

Plasma testosterone and arrhythmic events in male patients with arrhythmogenic right ventricular cardiomyopathy
por: Ren, Jie, et al.
Publicado: (2020)

The Efficacy of Anti-Arrhythmic Drugs in Children With Idiopathic Frequent Symptomatic or Asymptomatic Premature Ventricular Complexes With or Without Asymptomatic Ventricular Tachycardia: a Retrospective Multi-Center Study
por: Bertels, Robin A., et al.
Publicado: (2021)

Ventricular arrhythmia management in patients with genetic cardiomyopathies
por: Sharif, Zain I., et al.
Publicado: (2021)

Left ventricular shape predicts arrhythmic risk in fibrotic dilated cardiomyopathy
por: Balaban, Gabriel, et al.
Publicado: (2021)

Intramural mapping of intramural septal ventricular arrhythmias
por: Tam, Tsz‐kin, et al.
Publicado: (2022)

Idiopathic Outflow Tract Ventricular Arrhythmia Ablation: Pearls and Pitfalls
por: Liang, Jackson J, et al.
Publicado: (2019)

Hypertension and Arrhythmias: A Clinical Overview of the Pathophysiology-Driven Management of Cardiac Arrhythmias in Hypertensive Patients
por: Marazzato, Jacopo, et al.
Publicado: (2022)

Dexmedetomidine Reduces Incidences of Ventricular Arrhythmias in Adult Patients: A Meta-Analysis
por: Zhong, Qiaonan, et al.
Publicado: (2022)

Novel Anti-arrhythmic Medications in the Treatment of Atrial Fibrillation
por: Saklani, Pradyot, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_337ang3kisum50vfm8b9f5aahl